Haemophilus Influenzae Type b Conjugate Vaccine (Liaoning Chengda Biotechnology/Beijing Chengda Tianhe Biological Technology)
b型流感嗜血杆菌结合疫苗 （辽宁成大生物/北京成大天和生物科技）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHaemophilus Influenzae Type b Conjugate Vaccine (Liaoning Chengda Biotechnology/Beijing Chengda Tianhe Biological Technology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Chengda Tianhe Biological Technology Co LtdLiaoning Chengda Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Chengda Tianhe Biological Technology Co LtdLiaoning Chengda Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications +[7]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A